Kodiak Sciences (KOD) Assets Average (2018 - 2026)
Kodiak Sciences (KOD) reported Assets Average of $328.8 million for Q1 2026, up 3.8% on a YoY basis from $316.7 million in Q1 2025, and up 15.44% quarter-over-quarter from $284.8 million in Q4 2025.
Kodiak Sciences (KOD) Assets Average (2018 - 2026) Analysis & Trends
Kodiak Sciences has reported Assets Average for 9 years, with the latest figure at $328.8 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 3.8% year-over-year to $328.8 million; the trailing twelve-month figure through Mar 2026 stood at $328.8 million (up 3.8% YoY), and the FY2025 full-year result was $343.6 million, down 15.69% from the prior year.
- Assets Average for Q1 2026 stood at $328.8 million, up from $284.8 million in the prior quarter.
- The five-year high for Assets Average was $877.3 million in Q1 2022, with the low at $237.4 million in Q3 2025.
- Historically, Assets Average has averaged $503.2 million across 5 years, with a median of $457.1 million in 2024.
- Annual changes were most pronounced in 2025 — Assets Average sank 38.68% — and 2026, when it rose 3.8%.
- Kodiak Sciences' Assets Average stood at $695.3 million in 2022, then slipped by 26.15% to $513.5 million in 2023, then slumped by 31.04% to $354.1 million in 2024, then decreased by 19.58% to $284.8 million in 2025, then climbed by 15.44% to $328.8 million in 2026.
- The last three Assets Average figures came in at $328.8 million (Q1 2026), $284.8 million (Q4 2025), and $237.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 660.38 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 328.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 328.77 Mn |
| Dec 31, 2025 | 284.80 Mn |
| Sep 30, 2025 | 237.40 Mn |
| Jun 30, 2025 | 277.32 Mn |
| Mar 31, 2025 | 316.74 Mn |
| Dec 31, 2024 | 354.12 Mn |
| Sep 30, 2024 | 387.12 Mn |
| Jun 30, 2024 | 418.17 Mn |
| Mar 31, 2024 | 457.07 Mn |
| Dec 31, 2023 | 513.51 Mn |
| Sep 30, 2023 | 568.66 Mn |
| Jun 30, 2023 | 615.00 Mn |
| Mar 31, 2023 | 653.48 Mn |
| Dec 31, 2022 | 695.31 Mn |
| Sep 30, 2022 | 752.95 Mn |
| Jun 30, 2022 | 816.10 Mn |
| Mar 31, 2022 | 877.25 Mn |
| Dec 31, 2021 | 931.21 Mn |
| Sep 30, 2021 | 977.90 Mn |
| Jun 30, 2021 | 1.02 Bn |